Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations-Reference-Cited by-同舟云学术

Network analysis of immunotherapy-induced regressing tumours identifies novel synergistic drug combinations

Published:2015-07-21 Issue:1 Volume:5 Page:
ISSN:2045-2322
Container-title:Scientific Reports
language:en
Short-container-title:Sci Rep

Author:

Lesterhuis W. Joost,Rinaldi Catherine,Jones Anya,Rozali Esdy N.,Dick Ian M.,Khong Andrea,Boon Louis,Robinson Bruce W.,Nowak Anna K.,Bosco Anthony,Lake Richard A.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/srep12298.pdf

Reference50 articles.

1. Hodi, F. S. et al. Improved Survival with Ipilimumab in Patients with Metastatic Melanoma. New Engl J Med 363, 711–723, (2010).

2. Topalian, S. L. et al. Safety, activity and immune correlates of anti-PD-1 antibody in cancer. New Engl J Med 366, 2443–2454 (2012).

3. Lesterhuis, W. J., Haanen, J. B. & Punt, C. J. Cancer immunotherapy - revisited. Nat Rev Drug Discov 10, 591–600 (2011).

4. Page, D. B., Postow, M. A., Callahan, M. K., Allison, J. P. & Wolchok, J. D. Immune modulation in cancer with antibodies. Annu Rev Med 65, 185–202 (2014).

5. Wolchok, J. D. et al. Nivolumab plus ipilimumab in advanced melanoma. The New Engl J Med 369, 122–133 (2013).

Cited by 57 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Interferon-γ driven differentiation of monocytes into PD-L1⁺and MHC II⁺macrophages and the frequency of Tim-3⁺tumor-reactive CD8⁺T cells within the tumor microenvironment predict a positive response to anti-PD-1-based therapy in tumor-bearing mice;2024-08-04

2. Tretinoin improves the anti-cancer response to cyclophosphamide, in a model-selective manner;BMC Cancer;2024-02-13

3. Non-oncology drug (meticrane) shows anti-cancer ability in synergy with epigenetic inhibitors and appears to be involved passively in targeting cancer cells;Frontiers in Oncology;2023-05-19

4. Pan-cancer analysis identifies proteasome 26S subunit, ATPase (PSMC) family genes, and related signatures associated with prognosis, immune profile, and therapeutic response in lung adenocarcinoma;Frontiers in Genetics;2023-01-09

5. Deep dive into the immune response against murine mesothelioma permits design of novel anti-mesothelioma therapeutics;Frontiers in Immunology;2023-01-04